NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. It would not allow patients to smoke herbal marijuana or vape, but would allow forms including pills, oils, lozenges and patches.

Legislation 255

Legislation Patients Decriminalization Access 255

Cannabis Law Report

AUGUST 22, 2021

Biotech startup to bring safety and efficacy to the emerging psychedelic industry, brings on University of Michigan Researcher as Chief Science Officer. “The Janus particle solution will allow for time-released and combined therapies to be administered to patients, targeting specific indications. MIAMI , Aug.

Pharmaceutical 98

Pharmaceutical Medicine Research and Development Therapy 98

Cannabis Law Report

AUGUST 27, 2021

The Edmonton, Alberta-based cannabis giant also said that its subsidiary and Ethypharm were selected by the National Agency for the Safety of Medicines and Health Products to supply the entire medical cannabis dried flower range sourced from the company’s EU GMP facility in Denmark Aurora Nordic to French patients as part of the program.

Patients 105

Patients Programs Pharmaceutical Compliance 105

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business.

Marijuana 253

Marijuana Legalization Programs Oil 253

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. InMed has conducted preclinical pharmacology studies that suggest CBN in INM-755 may help relieve hallmark EB symptoms, including inflammation and pain, as well potentially restore the integrity of the skin in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Veriheal

SEPTEMBER 7, 2022

’s medical cannabis program come on the heels of a previously enacted emergency amendment focused on senior citizens: The Medical Marijuana Patient Access Extension Emergency Amendment Act of 2022 allowed D.C. A Temporary Triumph for Medical Cannabis Patients. The State of Patients’ Rights and Access in America Today.

Patients 98

Patients Programs Access Treatment 98

Project CBD

MARCH 8, 2019

Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. In response, veterinarians and others concerned for patient safety promoted a change in state law.

Pets 218

Pets Legalization Hemp Extraction 218

Cannabis Law Report

JULY 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. We remain encouraged as we continue our evaluations of MYMD-1 for efficacy and safety – especially as studies continue to suggest we may be able to address many of the concerns that are associated with the current drugs on the market today in these disease areas.”.

Pharmaceutical 81

Pharmaceutical Data Clinical Trials Research and Development 81

Cannabis Law Report

JUNE 10, 2021

–(BUSINESS WIRE)– CURE Pharmaceutical Holding Corp. We’ve been working to develop safe, accurately-dosed cannabis solutions for several years now and we believe that this collaboration will help us take that initiative to the next level and expand our reach,” said Rob Davidson, CURE Pharmaceutical CEO. OXNARD, Calif.–(BUSINESS

Pharmaceutical 75

Pharmaceutical DEA Research and Development THC 75

NORML

JANUARY 25, 2019

179: The VA Medicinal Cannabis Research Act of 2019 to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans. And a North Dakota bill to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes was defeated in a Senate committee this week.

Legislation 185

Legislation Patients Hemp Oil 185

Cannabis Law Report

JULY 14, 2021

Patients are looking to their medical providers for information on cannabis safety, potential for interactions with pharmaceuticals, and therapeutic applications. This position cripples the ability of clinicians to advise patients or to influence the burgeoning cannabis industry. As cannabis use expands in the U.S.,

Policy 105

Policy Medicine Research and Development Safety 105

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

NORML

JANUARY 11, 2019

Legislation is pending, Senate Bill 2134, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit patients to grow up to nine cannabis plants in a locked, enclosed facility, and to possess up to three ounces of home-grown medical cannabis. NH resident?

Legislation 231

Legislation Decriminalization Hemp Patients 231

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety.

Clinical Trials 81

Clinical Trials Patients THC Safety 81

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. About half to two-thirds of the cases get much better during adolescence[1]; however, adults will generally be more severe patients[2]. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

Cannabis Law Report

SEPTEMBER 10, 2021

Several thousand medical cannabis patients are waiting for the president of the Lower House, Bolsonaro’s close ally Arthur Lira, to put it to a vote. Associations like ABRACE, which is authorised to cultivate and process cannabis, cater to the many other patients who do not have the means to pay the exorbitant prices of imported cannabis oil.

Policy 103

Policy Oil Concentrates Pharmaceutical 103

NORML

FEBRUARY 29, 2020

The bill allows the department of health to issue permits to medical cannabis dispensaries for the delivery of medical cannabis and cannabis products to qualifying patients or primary caregivers if certain conditions are met. Legislation is pending, Senate Bill 2787, to regulate medical cannabis delivery services. HI resident? New Hampshire.

Legislation 163

Legislation Decriminalization Patients Edibles 163

NORML

FEBRUARY 1, 2019

Legislation is pending, House Bill 6849, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit medical cannabis patients to grow up to six cannabis plants. CT resident? Click here to email your lawmakers in support of home cultivation rights. IA resident?

Legislation 188

Legislation Decriminalization Access Patients 188

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. “ Off-label use ” (which is extremely common) is: the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.

Therapy 104

Therapy Legalization Chronic Pain DEA 104

MMJ Recs

JUNE 30, 2024

Cannabis-infused products, such as edibles and oils, have surged in popularity among medical marijuana patients seeking alternative methods of consumption. As more patients incorporate these products into their treatment regimens, grasping the intricacies of shelf life management becomes increasingly vital.

Edibles 111

Edibles Oil Packaging Patients 111

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

JUNE 12, 2021

MONTEREY, CA – Biopharmaceutical Research Company (BRC), an active Drug Enforcement Administration (DEA) license holder, and CURE Pharmaceutical Holding Corp. CURE has established itself as a leader in the oral application of cannabis-derived treatments, and we know we’ll be able to bring a lot of value to patients together.”.

DEA 45

DEA Pharmaceutical Research and Development Compliance 45

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” ” State Doctors Oppose Legalization in Alabama.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

LifeCannMD

MARCH 3, 2025

Today, she maintains a discreet, effective regimen that has reduced her pharmaceutical intake by over half. Elena’s story sound like many of our Miami patients who find that medical marijuana edibles offer relief that helps them on a medical and personal level.

Edibles 52

Edibles Marijuana Dispensary Patients 52

MMJ Recs

AUGUST 1, 2024

While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. Medical marijuana for HIV/AIDS offers a promising complementary treatment for patients.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

MMJ Recs

JUNE 26, 2020

The Sooner State has more dispensaries than any other state, as well as more MMJ patients per capita. Marijuana Use In Safety Sensitive Job Duties In Oklahoma. When OK legalized MMJ in 2018, it began providing licenses to businesses and MMJ cards to patients almost right away. Safety Sensitive jobs and work duties were detailed.

Marijuana 69

Marijuana Safety Pharmaceutical Patients 69

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

The Cannigma

MARCH 25, 2021

Sterling mentioned fears that officials may have about cannabis making its way out into the general population of the prison, though he added that’s a concern with any pharmaceutical provided by prison health services. Largely it’s the opaque legal and regulatory restrictions on cannabis which complicate the matter.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain. The report further breaks down use by specific cultivars.

Data 105

Data Clinical Trials Research and Development Indica 105

Veriheal

NOVEMBER 10, 2020

The experiment consists of a two-year cycle where up to 3,000 patients will be treated with medical cannabis. In conjunction with the ANSM, the Ministry of Health and Solidarity will decide on the following: The characteristics, composition, pharmaceutical form, and technical specifications of the medical cannabis products. .

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

Canna Care Docs

OCTOBER 3, 2023

On top of overwhelming struggles or feelings, patients who have been diagnosed with a terminal illness can face a broad range of both physical and psychological effects. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. “Our Work with U.S.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Cannabis Law Report

DECEMBER 3, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Chief Executive Officer of Marinus Pharmaceuticals. “We Webcast to be held Monday, December 6 at 1:00 p.m. ET (12:00 p.m. RADNOR, Pa.–(BUSINESS

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

Cannabis Law Report

JUNE 17, 2021

Patients are looking to their medical providers for information on cannabis safety, potential for interactions with pharmaceuticals, and therapeutic applications. This position cripples the ability of clinicians to advise patients or to influence the burgeoning cannabis industry. As cannabis use expands in the U.S.,

Policy 61

Policy Research and Development Medicine Safety 61

Cannabis Law Report

AUGUST 16, 2021

The Ridgell case is an appeal of the Department of Child Safety’s decision to keep a former employee of the department on the registry. Should the appeal be successful, it would set a precedent and help clarify the law for future cannabis patients who may get pregnant. Help battle the Department of Child Safety.

Safety 116

Safety Patients Cannabis Law 116

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. InMed has conducted preclinical pharmacology studies that suggest CBN in INM-755 may help relieve hallmark EB symptoms, including inflammation and pain, as well potentially restore the integrity of the skin in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40